Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
ADCT holding history
ADC Therapeutics SA in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,824,749
- Value
- $8.37M
- % of portfolio
- 1.4%
- Quarters held
- 16
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,824,749 | $8.37M | 1.4% | −475,251−5.7% | Reduced | Holders |
| Q1 2026 | 8,300,000 | $31.1M | 5.1% | −177,338−2.1% | Reduced | Holders |
| Q4 2025 | 8,477,338 | $29.9M | 6.2% | +1,005,035+13.5% | Added | Holders |
| Q3 2025 | 7,472,303 | $29.9M | 7.2% | −2,995,468−28.6% | Reduced | Holders |
| Q2 2025 | 10,467,771 | $28.1M | 6.8% | +924,767+9.7% | Added | Holders |
| Q1 2025 | 9,543,004 | $13.5M | 4.4% | +28,004+0.3% | Added | Holders |
| Q4 2024 | 9,515,000 | $18.9M | 5.3% | −121,237−1.3% | Reduced | Holders |
| Q3 2024 | 9,636,237 | $30.4M | 7.7% | +66,237+0.7% | Added | Holders |
| Q2 2024 | 9,570,000 | $30.2M | 9.0% | +2,519,700+35.7% | Added | Holders |
| Q1 2024 | 7,050,300 | $31.7M | 8.8% | +578,500+8.9% | Added | Holders |
| Q4 2023 | 6,471,800 | $10.7M | 4.3% | +1,069,759+19.8% | Added | Holders |
| Q3 2023 | 5,402,041 | $4.85M | 1.5% | −181,859−3.3% | Reduced | Holders |
| Q2 2023 | 5,583,900 | $12.0M | 3.5% | +2,326,540+71.4% | Added | Holders |
| Q1 2023 | 3,257,360 | $6.35M | 3.0% | +2,794,050+603.1% | Added | Holders |
| Q4 2022 | 463,310 | $1.78M | 1.0% | +215,680+87.1% | Added | Holders |
| Q3 2022 | 247,630 | $1.19M | 0.7% | +247,630 | New | Holders |